Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Petlife Pharmaceuticals, Inc. (GEUR) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Petlife Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1354591.
Total stock buying since 2015: $1,226,158,944.
Total stock sales since 2015: $0.
Total stock option exercises since 2015: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2018 | 305,000 | $1,225,185,000 | 0 | $0 | 0 | $0 |
| 2017 | 40,000 | $10,000 | 0 | $0 | 0 | $0 |
| 2016 | 1,258,470 | $876,287 | 0 | $0 | 0 | $0 |
| 2015 | 250,210 | $87,657 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2018-02 | 305,000 | $1,225,185,000 | 0 | $0 | 0 | $0 |
| 2017-02 | 40,000 | $10,000 | 0 | $0 | 0 | $0 |
| 2016-05 | 218,470 | $273,087 | 0 | $0 | 0 | $0 |
| 2016-02 | 1,040,000 | $603,200 | 0 | $0 | 0 | $0 |
| 2015-12 | 100,000 | $25,000 | 0 | $0 | 0 | $0 |
| 2015-11 | 100,000 | $25,000 | 0 | $0 | 0 | $0 |
| 2015-05 | 50,210 | $37,657 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-02-28 | Campbell Vyvyan | Buy | 305,000 | 4,017.00 | 1,225,185,000 |
| 2017-02-23 | Campbell Vyvyan | Buy | 40,000 | .25 | 10,000 |
| 2016-05-15 | Campbell Vyvyan | Buy | 218,470 | 1.25 | 273,087 |
| 2016-02-12 | Salvagno Ralph T (CEO) | Buy | 1,040,000 | .58 | 603,200 |
| 2015-12-29 | Salvagno Ralph T (CEO) | Buy | 100,000 | .25 | 25,000 |
| 2015-11-09 | Campbell Vyvyan | Buy | 100,000 | .25 | 25,000 |
| 2015-05-30 | Campbell Vyvyan | Buy | 50,210 | .75 | 37,657 |
Insider trading activities including stock purchases, stock sales, and option exercises of GEUR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Petlife Pharmaceuticals, Inc. (symbol GEUR, CIK number 1354591) see the Securities and Exchange Commission (SEC) website.